| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.098 | 0.03 |